- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 133
Sanofi sends Enable Injections part way to $50m
The drug injection device developer has reached the first close of a $50m round, with Sanofi leading the tranche and Cincinnati Children’s Hospital and Cleveland Clinic also investing.
Oct 26, 2018100 Thieves takes funding haul to $25m
Media holding company WndrCo is among the investors in a series A round that helped eSports and lifestyle brand 100 Thieves take its total funding to $25m.
Oct 25, 2018ASAP engineers ZF Friedrichshafen deal
ZF Friedrichshafen has paid an undisclosed sum for a stake in engineering services provider ASAP Holding sized at over 35%.
Oct 24, 2018Microbiotica digests $5.2m investment
Seventure Partners has injected $5.2m into the Sanger Institute spinout, which has now raised $15.2m from investors also including IP Group and Cambridge Innovation Capital.
Oct 24, 2018Corporates hit Click in $19m round
Drug developers Sanofi and Hikma both contributed to a funding round for health management app developer Click Therapeutics to bring its total financing to more than $26m.
Oct 22, 2018Corporate venturing deal net: 15-19 October 2018
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Oct 19, 2018RapidAim hits funding target
The Csiro Innovation Fund has invested $890,000 in RapidAim, co-founded by three Csiro researchers, to support a trial of a fruit fly monitoring system.
Oct 19, 2018Corporates drive Momenta to $1bn valuation
Tencent and existing backer Nio Capital both invested as autonomous driving software developer Momenta took its overall funding to $200m.
Oct 19, 2018Oh My Green tosses together $20m
Stanford-Start X Fund has put its weight behind Oh My Green's seed round, which also attracted a host of venture capital firms.
Oct 18, 2018Amgen inserts $66m into Oxford Nanopore
Oxford Nanopore has secured $66m from Amgen, after the latter’s subsidiary Decode Genetics used the spinout’s technology to sequence hundreds of human genomes.
Oct 18, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


